Jane Street
DSGN icon

Jane Street’s Design Therapeutics DSGN Stock Holding History

Jane Street’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,900
Closed -$102K – 11875
2025
Q4 		$102K Buy
+10,900
New +$85.3K ﹤0.01% 10178
2023
Q2 		– Sell
-40,000
Closed -$231K – 8843
2023
Q1 		$231K Hold
40,000
– – ﹤0.01% 7617
2022
Q4 		$410K Buy
+40,000
New +$542K ﹤0.01% 6480

Other funds holding DSGN

SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Jane Street's DSGN Position: Q1 2026 in Review

Jane Street reduced its Design Therapeutics (DSGN) stake by 54% in Q1 2026, selling an estimated $1.24M and leaving 103,902 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #6275.

Jane Street first reported a position in DSGN in Q2 2022 and has held it in 12 quarters since. The position peaked at $2.12M in Q4 2025. 125 funds tracked by Wall St. Rank hold DSGN as of Q1 2026.

  • Jane Street held 103,902 shares of Design Therapeutics worth $1.11M as of Q1 2026.
  • Jane Street sold 122,610 Design Therapeutics shares in Q1 2026, an estimated $1.24M.
  • Design Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #6275 holding.
  • Jane Street first reported a position in Design Therapeutics in Q2 2022 and has held it in 12 quarters since.
  • Jane Street's Design Therapeutics position peaked at $2.12M in Q4 2025.
  • 125 funds tracked by Wall St. Rank held Design Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.